Unparalleled knowledge and experience

Prof Sir Martin Landray is CEO of Protas, Professor of Medicine and Epidemiology at Oxford Population Health and a consultant hospital physician. He has over 20 years’ experience of leading large, randomised trials and is a joint lead of the RECOVERY trial of treatments for COVID-19. He works closely with regulators, industry, academia, patient groups and government organisations to improve all aspects of clinical trials.

Dr Abby Taylor is COO and is responsible for the efficient establishment of Protas and our operations. Abby was the Associate Director of Strategy and Data Insights for the Wellcome Trust, where she spent almost a decade leading the development and delivery of many of Wellcome’s major strategic initiatives and its international expansion. Abby has a PhD in biochemistry.

Dr Tim Peakman is Chief Clinical Operations Officer at Protas and is responsible for the efficient establishment and operation of trials. Before joining Protas he worked at University of Leeds as Chief Operating Officer and for 14 years at UK Biobank as Deputy Chief Executive helping to establish and run this study involving 500,000 participants. He holds an MBA from Henley Management College and in 2014 was awarded an OBE in the Queen’s birthday honours for services to medical sciences.

Richard Eales is CFO at Protas and is responsible for oversight of all financial matters. Richard is also Interim CFO at the Wellcome Trust and a member of the Audit Committee of Diamond Light Source, the UK’s national synchrotron science facility.

Professor Richard Haynes is Chief Scientist of Protas, Professor of Renal Medicine and Clinical Trials at Oxford Population Health and a consultant kidney doctor in the NHS. He has worked on and led large, randomised trials for over 15 years in cardiovascular, kidney and infectious diseases, and has a keen interest in ensuring that all areas of health benefit from streamlined trials.

Stefan Blixen-Finecke is Protas’ CIO and is responsible for the efficient establishment and operation of our information technology services, including our unified clinical trials management platform, Cantata. Before joining Protas, Stefan was the Chief Technology Officer at the European Medicines Agency, where he led the development of strategic platforms underpinning medicines regulation in Europe. He has also held technology leadership roles at the Financial Conduct Authority and Telenor Denmark.